Skip to content

Common Stock at other companies

Insulet logo
InsuletPODD
100M0.0%
Medtronic logo
MedtronicMDT
$0
AdaptHealth logo
AdaptHealthAHCO
$14K+7.7%
Mannkind logo
MannkindMNKD
$3.09M+1.6%
Omnicell logo
OmnicellOMCL
100M0.0%
ICU Medical logo
ICU MedicalICUI
80M0.0%

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.08B-19.8%
Enterprise value$1.64B-8.5%
P/S1.1×-0.3×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's common stock?
Tandem Diabetes Care (TNDM) reported common stock of 200M in Q1 2026.
How has Tandem Diabetes Care's common stock changed year-over-year?
Tandem Diabetes Care's common stock decreased by 0.0% year-over-year, from 200M to 200M.
What is the long-term trend for Tandem Diabetes Care's common stock?
Over 5 years (2020 to 2025), Tandem Diabetes Care's common stock has grown at a 403.2% compound annual growth rate (CAGR), from 62K to 200M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).